Comparative effects of secondary bile acids, deoxycholic and lithocholic acids, on aberrant crypt foci growth in the postinitiation phases of colon carcinogenesis

Nutrition and Cancer

Volumn 31, Issue 2, 1998, Pages 81-89

  Baijal, Priti K ^a   Fitzpatrick, Dennis W ^a   Bird, Ranjana P ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; BILE ACID; DEOXYCHOLIC ACID; LITHOCHOLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; DIET; DIETARY INTAKE; INTESTINE CRYPT; MALE; NONHUMAN; RAT; TISSUE DISTRIBUTION;

ANIMALIA; GLYCINE MAX;

EID: 0031722771     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635589809514685     Document Type: Article

References (49)

1. Kim, Y, and Mason, JB: Nutrition chemoprevention of gastrointestinal cancers: a critical review. Nutr Rev 54, 259-279, 1996.
2. Reddy, BS: Dietary fat and colon cancer: animal model studies. Lipids 27, 807-813, 1992.
3. Bruce, WR: Recent hypothesis for the origin of colon cancer. Cancer Res 47, 4237-4242, 1987.
4. Newmark, HL, and Lipkin, M: Calcium, vitamin D, and colon cancer. Cancer Res 52 Suppl, 2067s-2070s, 1992.
5. Narisawa, T, Magadia, NE, Weisburger, JH, and Wynder, EL: Promoting effect of bile acids on colon carcinogenesis after intrarectal instillation of N-methyl-N-nitro-N-nitrosoguanidine in rats. JNCI 53, 1093-1097, 1974.
6. Reddy, BS, Watanabe, K, Weisburger, JH, and Wynder, EL: Promoting effect of bile acids in colon carcinogenesis in germ free and conventional F344 rats. Cancer Res 37, 3238-3242, 1977.
7. Cohen, BI, and Deschner, EE: The role of bile acids in colorectal carcinogenesis. In Colorectal Cancer: From Pathogenesis to Prevention, HK Seitz, UA Simanowski, and NA Wright (eds). New York: Springer-Verlag, 1989, pp 125-138.
8. Corpet, DE, Taché, S, and Peiffer, G: Colon tumor promotion: is it a selection process? Effects of cholate, phytate, and food restriction in rats on proliferation and apoptosis in normal and aberrant crypts. Cancer Lett 114, 135-138, 1997.
9. Cohen, BI, Raicht, RF, Deschner, EE, Takahashi, M, Sarwal, AN, et al.: Effect of cholic acid feeding on N-methyl-N-nitrosourea-induced colon tumours and cell kinetics in rats. JNCI 64, 573-578, 1980.
10. Summerton, J, Goeting, N, Trotter, GA, and Taylor, I: Effect of deoxycholic acid on the tumor incidence, distribution and receptor status of colorectal cancer in the rat model. Digestion 31, 77-81, 1985.
11. McSherry, CK, Cohen, BI, Bokkenheuser, VD, Mosbach, EH, Winter, J, et al.: Effects of calcium and bile acid feeding on colon tumours in the rat. Cancer Res 49, 6039-6043, 1989.
12. Magnuson, BA, Carr, I, and Bird, RP: Ability of aberrant crypt foci characteristics to predict colonie tumour incidence in rats fed cholic acid. Cancer Res 53, 4499-4504, 1993.
13. Earnest, DL, Holubec, H, Wali, RK, Jolley, CS, Bissonette, M, et al.: Chemoprevention of azoxymethane-induced colonie carcinogenesis by supplemental dietary ursodeoxychlic acid. Cancer Res 54, 5071-5074, 1994.
14. Bird, RP: Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett 93, 55-71, 1995.
15. Bird, RP: Further investigation of the effect of cholic acid on the induction, growth characteristics and stability of aberrant crypt foci in rat colon. Cancer Lett 88, 201-209, 1995.
16. Corpet, DE, Stamp, D, Medline, A, Minkin, S, Archer, MC, et al.: Promotion of colonic microadenoma growth in mice fed cooked sugar or cooked casein and fat. Cancer Res 50, 6955-6958, 1990.
17. Lafave, LMZ, Kumarathasan, P, and Bird, RP: Effect of dietary fat on colonic protein kinase C and induction of aberrant crypt foci. Lipids 29, 693-700, 1994.
18. Pretlow, TP: Alterations associated with early neoplasia in the colon. In Biochemical and Molecular Aspects of Selected Cancers, TG Pretlow and TP Pretlow (eds). New York: Academic, 1994, vol 2, pp 93-141.
19. Shirtliff, N, Carr, I, and Bird, RP: Variable effect of cholic acid on the induction and growth of aberrant crypt foci and colonic tumours in Sprague Dawley rats (abstr). Proc Am Assoc Cancer Res 34, 792, 1993.
20. Lasko, CM, and Bird, RP: Modulation of aberrant crypt foci by dietary fat and caloric restriction. The effects of delayed intervention. Cancer Epidemiol Biomarkers Prev 4, 49-55, 1995.
21. Reeves, PG, Nielsen, FH, and Fahey, GC: AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123, 1939-1951, 1993.
22. Bird, RP, Yao, K, Lasko, CM, and Good, CK: Inability of low-or high-fat diet to modulate late stages of colon carcinogenesis in Sprague-Dawley rats. Cancer Res 56, 2896-2899, 1996.
23. Guengerich, FP: Analysis and characterization of enzymes. In Principles and Methods of Toxicology, 3rd ed, AW Hayes (ed). New York: Raven, 1994, pp 1259-1314.
24. Baijal, PK, Fitzpatrick, DW, and Bird, RP: Phenobarbital and 3-methylcholanthrene treatment alters phase I and II enzymes and the sensitivity of the rat colon to the carcinogenic activity of azoxymethane. Food Chem Toxicol 35, 789-798, 1997.
25. Bird, RP: Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 37, 147-151, 1987.
26. Hoops, TC, and Traber, PG: Molecular pathogenesis of colorectal cancer. In Hematology/Oncology Clinics of North America, Colorectal Carcinoma, GR Lichtenstein and DG Haller (eds). Toronto: Saunders, 1997, vol 11, pp 609-633.
27. Steele, VE, Moon, RC, Lubet, RA, Grubbs, CJ, Reddy, BS, et al.: Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: methods and results from the NCI chemoprevention drug development program. J Cell Biochem 20 Suppl, 32-54, 1994.
28. Hatono, S, Jimenez, A, and Wargovich, MJ: Chemopreventive effect of S-allylcysteine and its relationship to the detoxification enzyme glutathione S-transferase. Carcinogenesis 17, 1041-1044, 1996.
29. Seraj, MJ, Umemoto, A, Kajikawa, A, Mimura, S, Kinouchi, T, et al.: Effects of dietary bile acids on formation of azoxymethane-induced aberrant crypt foci in F344 rats. Cancer Lett 115, 97-103, 1997.
30. Shivapurkar, N, Tang, ZC, and Alabaster, O: The effect of high-risk and low-risk diets on aberrant crypt and colonie tumor formation in Fischer-344 rats. Carcinogenesis 13, 887-890, 1992.
31. Bird, RP, and Lafave, LMZ: Varying effects of dietary lipids and azoxymethane on early stages of colon carcinogenesis: enumeration of aberrant crypt foci and proliferative indices. Cancer Detect Prev 19, 308-315, 1995.
32. Morotomi, M, Sakaitani, Y, Satou, M, Takahashi, T, Takagi, A, et al.: Effects of a high-fat diet on azoxymethane-induced aberrant crypt foci and fecal biochemistry and microbial activity in rats. Nutr Cancer 27, 84-91, 1997.
33. Hill, MJ, Crowther, JS, and Drasar, BS: Bacteria and etiology of cancer of the large bowel. Lancet 1, 95-100, 1971.
34. Owen, RW, Dodo, M, Thompson, MH, and Hill, MJ: The fecal ratio of lithocholic acid to deoxycholic acid may be an important etiological factor in colo-rectal cancer. Biochem Soc Trans 12, 861, 1984.
35. Breuer, NF, Dommes, P, Jaekel, S, and Goebell, H: Fecal bile acid excretion pattern in colonic cancer patients. Dig Dis Sci 30, 852-859, 1985.
36. Owen, RW, Henly, PJ, Thompson, MH, and Hill, MJ: Steroids and cancer: fecal bile acid screening for early detection of cancer risk. J Steroid Biochem 24, 391-394, 1986.
37. Zuccato, E, Venturi, M, Di Leo, G, Colombo, L, Bertolo, C, et al.: Role of bile acids and metabolic activity of colonic bacteria in increased risk of colon cancer after cholecystectomy. Dig Dis Sci 38, 514-519, 1993.
38. Magnuson, BA, Shirtliff, N, and Bird, RP: Resistance of aberrant crypt foci to apoptosis induced by azoxymethane in rats chronically fed cholic acid. Carcinogenesis 15, 1459-1462, 1994.
39. Pereira, MA, Barnes, LH, Steele, VE, Kelloff, GV, and Lubet, RA: Piroxicam-induced regression of azoxymethane-induced aberrant crypt foci and prevention of colon cancer. Carcinogenesis 17, 373-376, 1996.
40. Shpitz, B, Hay, K, Medline, A, Bruce, WR, Bull, SB, et al.: Natural history of aberrant crypt foci. A surgical approach. Dis Colon Rectum 39, 763-767, 1996.
41. Farber, E, and Rubin, H: Cellular adaptation in the origin and development of cancer. Cancer Res 51, 2751-2761, 1991.
42. Winawer, SJ, Enker, WE, and Levin, B: Colorectal cancer. In Gastrointestinal Cancer, SJ Winawer and RC Kurtz (eds). New York: Gower, 1992, pp4.1-4.40.
43. Van Gorkom, BAP, Cats, A, Van Der Meer, R, Kuipers, F, Verschueren, RCJ, et al.: Effects of hemicolectomy on bile acid metabolism in relation to colon carcinogenesis in man. Eur J Clin Invest 27, 589-594, 1997.
44. Schneider, H: A factor in the increased risk of colorectal cancer due to ingestion of animal fat is inhibition of colon epithelial cell glutathione S-transferase, an enzyme that detoxifies mutagens. Med Hypotheses 39, 119-122, 1992.
45. Schneider, H, Fiander, H, Latta, RK, and Ross, NW: Bile acid inhibition of xenobiotic-metabolizing enzymes is a factor in the mechanism of colon carcinogenesis: tests of aspects of the concept with glucuronosyltransferase. Eur J Cancer Prev 2, 393-400, 1993.
46. Baijal, PK, Fitzpatrick, DW, and Bird, RP: Feeding bile acids modulates colonic xenobiotic-metabolizing enzymes: comparative effects of cholic, deoxycholic, lithocholic and ursodeoxycholic acids. Food Chem Toxicol 36, 601-607, 1998.
47. Shirtliff, N, and Bird, RP: Growth features of aberrant crypt foci that resist modulation by cholic acid. Carcinogenesis 17, 2093-2096, 1996.
48. Giovannucci, E: Insulin and colon cancer. Cancer Causes Control 6, 164-179, 1995.
49. Tran, TT, Medline, A, and Bruce, WR: Insulin promotion of colon tumors in rats. Cancer Epidemiol Biomarkers Prev 5, 1013-1015, 1996.